menu
    • menu

    Company profile for Exact Sciences

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Exact Sciences Corp. is a molecular diagnostics company specialising in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer, in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Exact SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5505 Endeavor Lane Madison, WI 53719
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.exactsciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/exact-sciences/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/exactsciences

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abbott Trims 2026 Profit Forecast On Exact Deal Hit, Shares Fall
    Abbott Trims 2026 Profit Forecast On Exact Deal Hit, Shares Fall

    16 Apr 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-first-quarter-results-beat-cancer-diagnostics-medical-device-strength-2026-04-16/

    REUTERS
    16 Apr 2026
    Share Share
    Abbott Completes Acquisition Of Exact Sciences
    Abbott Completes Acquisition Of Exact Sciences

    23 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbott-completes-acquisition-of-exact-sciences-302722046.html

    PR NEWSWIRE
    23 Mar 2026
    Share Share
    Abbott To Finalize Exact Sciences Acquisition On March 23, 2026
    Abbott To Finalize Exact Sciences Acquisition On March 23, 2026

    20 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbott-acquisition-of-exact-sciences-set-to-close-on-march-23-2026-302719347.html

    PR NEWSWIRE
    20 Mar 2026
    Share Share
    Exact Sciences To Present New Molecular Residual Disease
    Exact Sciences To Present New Molecular Residual Disease

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260317158639/en/Exact-Sciences-to-Present-New-Molecular-Residual-Disease-and-Multi-Cancer-Early-Detection-Data-at-AACR-2026

    BUSSINESSWIRE
    17 Mar 2026
    Share Share
    Exact Sciences Unveils Record 2025 Q4 And Full-Year Performance
    Exact Sciences Unveils Record 2025 Q4 And Full-Year Performance

    13 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260213963431/en/Exact-Sciences-Announces-Record-Fourth-Quarter-and-Full-Year-2025-Results

    BUSINESSWIRE
    13 Feb 2026
    Share Share
    Geneoscopy Invalidates Exact Sciences' '746 Patent In Second
    Geneoscopy Invalidates Exact Sciences' '746 Patent In Second

    06 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260206045746/en/Geneoscopy-Wins-Second-Patent-Trial-and-Appeal-Board-Decision-Invalidating-All-Challenged-Claims-of-Exact-Sciences-746-Patent

    BUSINESSWIRE
    06 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search